These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29298359)

  • 1. Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion.
    Garcia J; Garg A; Song Y; Fotios A; Andersen C; Garg S
    PLoS One; 2018; 13(1):e0190577. PubMed ID: 29298359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.
    Riera P; Garrido-Alejos G; Cardenete J; Moliner E; Zapico-Muñiz E; Cardona D; Garin N
    Nutr Clin Pract; 2018 Oct; 33(5):694-700. PubMed ID: 29464781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.
    Aeberhard C; Steuer C; Saxer C; Huber A; Stanga Z; Mühlebach S
    Eur J Pharm Sci; 2017 Jan; 96():449-455. PubMed ID: 27742594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants.
    Lago P; Salvadori S; Opocher F; Ricato S; Chiandetti L; Frigo AC
    Neonatology; 2014; 105(1):46-54. PubMed ID: 24281435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Influencing Escherichia coli and Enterococcus durans Growth in Parenteral Nutrition With and Without Lipid Emulsion to Inform Maximum Duration of Infusion Policy Decisions.
    Austin PD; Hand KS; Elia M
    JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):953-65. PubMed ID: 24969406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of temperature and handling conditions on lipid emulsion stability in veterinary parenteral nutrition admixtures during simulated intravenous administration.
    Thomovsky EJ; Backus RC; Mann FA; Richmond CK; Wagner-Mann CC
    Am J Vet Res; 2008 May; 69(5):652-8. PubMed ID: 18447797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)--a double-blind, randomised, multicentre study in adults.
    Klek S; Chambrier C; Singer P; Rubin M; Bowling T; Staun M; Joly F; Rasmussen H; Strauss BJ; Wanten G; Smith R; Abraham A; Szczepanek K; Shaffer J
    Clin Nutr; 2013 Apr; 32(2):224-31. PubMed ID: 22796064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.
    Boullata JI; Gilbert K; Sacks G; Labossiere RJ; Crill C; Goday P; Kumpf VJ; Mattox TW; Plogsted S; Holcombe B;
    JPEN J Parenter Enteral Nutr; 2014; 38(3):334-77. PubMed ID: 24531708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Must fat emulsions and parenteral nutrition solutions be given through separate circuits?
    Tannuri U; Chapchap P; Sesso A; Maksoud JG
    J Pediatr Surg; 1987 Feb; 22(2):132-4. PubMed ID: 3102716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral and intravenous Ibuprofen for medical closure of patent ductus arteriosus: which one is better?
    Olukman O; Calkavur S; Ercan G; Atlihan F; Oner T; Tavli V; Kultursay N
    Congenit Heart Dis; 2012; 7(6):534-43. PubMed ID: 22613269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro compatibility studies of vancomycin with ready-to-use parenteral nutrition admixtures for safer clinical practice.
    Stawny M; Nadolna M; Jelińska A
    Clin Nutr; 2020 Aug; 39(8):2539-2546. PubMed ID: 31784302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stability of the mixture of a new fat emulsion with parenteral nutrition solutions].
    Tannuri U; Coelho MC; Sesso A; Maksoud JG
    AMB Rev Assoc Med Bras; 1989; 35(1):5-8. PubMed ID: 2513624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral nutrition admixtures for pediatric patients compounded with highly refined fish oil-based emulsion: assessment of physicochemical stability.
    Forchielli ML; Bonoli A; Preite I; Stancari A; Maselli S; Guarguaglini AM; Mignini I; Masi M; Puggioli C; Bersani G
    Clin Nutr; 2014 Dec; 33(6):1127-31. PubMed ID: 24411491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.
    Dani C; Poggi C; Mosca F; Schena F; Lista G; Ramenghi L; Romagnoli C; Salvatori E; Rosignoli MT; Lipone P; Comandini A
    Trials; 2016 Apr; 17():182. PubMed ID: 27038924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants.
    Aranda JV; Clyman R; Cox B; Van Overmeire B; Wozniak P; Sosenko I; Carlo WA; Ward RM; Shalwitz R; Baggs G; Seth A; Darko L
    Am J Perinatol; 2009 Mar; 26(3):235-45. PubMed ID: 19067286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants?
    Akar M; Yildirim TG; Sandal G; Bozdag S; Erdeve O; Altug N; Uras N; Oguz SS; Dilmen U
    Cardiol Young; 2017 Apr; 27(3):507-511. PubMed ID: 27319277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
    Campos-Baeta Y; Saavedra-Mitjans M; Garin N; Cardenete J; Cardona D; Riera P
    Nutr Clin Pract; 2020 Oct; 35(5):967-972. PubMed ID: 31482649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.